Latest News

ROBUST I: Optilume maintains durable efficacy, safety for urethral strictures
ROBUST I: Optilume maintains durable efficacy, safety for urethral strictures

January 20th 2025

Functional success was achieved in 58% of patients at 5-year follow-up.

Published data show promise of frontline belzutifan/cabozantinib for ccRCC
Published data show promise of frontline belzutifan/cabozantinib for ccRCC

January 20th 2025

Leveraging the full potential of APPs: Mark Edney, MD, on tips for successful collaboration
Leveraging the full potential of APPs: Mark Edney, MD, on tips for successful collaboration

January 18th 2025

Enzalutamide included in next round of Medicare drug price negotiations
Enzalutamide included in next round of Medicare drug price negotiations

January 17th 2025

Illuccix approved in Europe for detection of PSMA-positive lesions
Illuccix approved in Europe for detection of PSMA-positive lesions

January 17th 2025

Latest Videos

Latest News

© 2025 MJH Life Sciences

All rights reserved.